Yekeduz, E. Et Al. 2021. Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. INTERNATIONAL JOURNAL OF CANCER , vol.149, no.7 , 1455-1462.

Yekeduz, E., Trapani, D., Xu, W., de Vries, E. G. E., Labaki, C., Gyawali, B., ... Gulati, S.(2021). Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. INTERNATIONAL JOURNAL OF CANCER , vol.149, no.7, 1455-1462.

Yekeduz, EMRE Et Al. "Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors," INTERNATIONAL JOURNAL OF CANCER , vol.149, no.7, 1455-1462, 2021

Yekeduz, EMRE Et Al. "Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors." INTERNATIONAL JOURNAL OF CANCER , vol.149, no.7, pp.1455-1462, 2021

Yekeduz, E. Et Al. (2021) . "Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors." INTERNATIONAL JOURNAL OF CANCER , vol.149, no.7, pp.1455-1462.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors}, journal={INTERNATIONAL JOURNAL OF CANCER}, year=2021, pages={1455-1462} }